Portside Wealth Group LLC Purchases Shares of 2,480 CME Group Inc. (NASDAQ:CME)

Portside Wealth Group LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,480 shares of the financial services provider’s stock, valued at approximately $488,000.

Other large investors also recently made changes to their positions in the company. Gold Investment Management Ltd. acquired a new stake in CME Group during the fourth quarter worth approximately $26,000. Salomon & Ludwin LLC acquired a new position in CME Group in the 1st quarter valued at $28,000. Northwest Financial Advisors bought a new position in CME Group during the 4th quarter worth $28,000. Rise Advisors LLC bought a new stake in shares of CME Group in the first quarter valued at about $41,000. Finally, McClarren Financial Advisors Inc. boosted its holdings in CME Group by 89.5% in the 1st quarter. McClarren Financial Advisors Inc. now owns 216 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 102 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other CME Group news, Director Elizabeth A. Cook sold 1,000 shares of the company’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $211.52, for a total transaction of $211,520.00. Following the sale, the director now directly owns 18,241 shares of the company’s stock, valued at $3,858,336.32. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,650 shares of company stock worth $928,776. 0.30% of the stock is owned by company insiders.

CME Group Stock Up 1.3 %

Shares of CME traded up $2.59 on Friday, reaching $207.88. The company’s stock had a trading volume of 1,115,669 shares, compared to its average volume of 1,947,617. The stock has a market capitalization of $74.85 billion, a PE ratio of 23.65, a PEG ratio of 6.27 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80. The firm has a fifty day moving average of $198.53 and a 200-day moving average of $207.04.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.30 EPS. Equities analysts predict that CME Group Inc. will post 9.8 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Bank of America raised their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Piper Sandler lowered their price target on shares of CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a report on Thursday, July 25th. Barclays raised their price objective on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Finally, Rosenblatt Securities reissued a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $213.27.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.